Tower Research Capital (TRC)’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.77K | Buy |
+1,156
| New | +$3.77K | ﹤0.01% | 4437 |
|
|
2024
Q4 | – | Sell |
-2,544
| Closed | -$4.3K | – | 5903 |
|
|
2024
Q3 | $4.3K | Sell |
2,544
-783
| -24% | -$1.32K | ﹤0.01% | 4598 |
|
|
2024
Q2 | $8.12K | Buy |
3,327
+1,184
| +55% | +$2.89K | ﹤0.01% | 4394 |
|
|
2024
Q1 | $10.1K | Buy |
2,143
+173
| +9% | +$816 | ﹤0.01% | 3744 |
|
|
2023
Q4 | $9.06K | Buy |
1,970
+1,052
| +115% | +$4.84K | ﹤0.01% | 4441 |
|
|
2023
Q3 | $2.39K | Sell |
918
-1,876
| -67% | -$4.88K | ﹤0.01% | 5164 |
|
|
2023
Q2 | $13.5K | Buy |
2,794
+1,310
| +88% | +$6.34K | ﹤0.01% | 3736 |
|
|
2023
Q1 | $10K | Buy |
1,484
+874
| +143% | +$5.89K | ﹤0.01% | 4381 |
|
|
2022
Q4 | $7K | Sell |
610
-684
| -53% | -$7.85K | ﹤0.01% | 4592 |
|
|
2022
Q3 | $10K | Buy |
1,294
+889
| +220% | +$6.87K | ﹤0.01% | 4551 |
|
|
2022
Q2 | $2K | Sell |
405
-108
| -21% | -$533 | ﹤0.01% | 5573 |
|
|
2022
Q1 | $13K | Buy |
513
+491
| +2,232% | +$12.4K | ﹤0.01% | 3989 |
|
|
2021
Q4 | $1K | Sell |
22
-81
| -79% | -$3.68K | ﹤0.01% | 5867 |
|
|
2021
Q3 | $10K | Buy |
103
+90
| +692% | +$8.74K | ﹤0.01% | 4329 |
|
|
2021
Q2 | $1K | Buy |
13
+3
| +30% | +$231 | ﹤0.01% | 5225 |
|
|
2021
Q1 | $4K | Buy |
+10
| New | +$4K | ﹤0.01% | 4798 |
|